Effects on Glycemia and Insulinemia of Different Grape Varieties (SUGARGAP)

December 19, 2024 updated by: Santiago Navas, Clinica Universidad de Navarra, Universidad de Navarra

Assessment of the Effect of Different Varieties of Grapes on Postprandial Glycemia and Insulinemia

The goal of this intervention study is to examine the glucose increase in blood, during 2 hours after consuming different varieties of grapes, in men and women with normal or excess body weight. The main question it aims to answer is:

can a variety of red grape reduce the glucose curve compared to a reference variety?

Participants will have to attend the Center for nutrition research facilities in three occasions, fasted for at least 8 hours. Once there, they will be measured and monitored. A canula will be inserted and once they finish eating 300g of grapes, blood extractions will be performed at minutes 15, 30, 60, 90 and 120.

Study Overview

Detailed Description

The main purpose of this study is to evaluate how the glucose and insulin curves develop after consuming different grapes varieties. Still, we also want to evaluate how the serum metabolome changes with the three varieties after 120 minutes. Therefore, a metabolomic study will be done in samples of volunteers at this time point.

The intervention is longitudinal and in three arms (one per variety). Due to the harvest of the different varieties, it cannot be crossover, but each subject will consume the three varieties.

At each visit, the subjects will undergo the same schedule:

  • Arrival in a fasting state of at least 8 hours.
  • Insertion of cannula and extraction of fasting samples
  • Consumption of approximately 300 g of grapes (50 g of Carbohydrates).
  • Extraction of blood samples at 15, 30, 60, 90 and 120 minutes.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Navarra
      • Pamplona, Navarra, Spain, 31008
        • Center for Nutrition Research. University of Navarra

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Baseline glycaemia between 70 and 100 mg/dL
  • BMI between 18.5 kg/m2 and 29.9 kg/m2.
  • Absence of disease or alterations related to gastrointestinal status.
  • Signed written informed consent.

Exclusion Criteria:

  • Glycaemic levels out of the reference inclusion criteria (below 70 or over 100 mg/dL)
  • Subjects presenting BMI out of the limits set.
  • Subjects with unstable body weight the three months prior the start of the study (+/- 3 Kg)
  • Subjects not able to attend the preestablished visits
  • Women pregnant or lactating
  • Subjects undergoing pharmacological treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Variety 1 (timpson)
Reference variety
Reference grape variety
Active Comparator: Variety 2 (18INV-1438-10)
First comparator
First grape variety to evaluate
Active Comparator: Variety 3 (18-1465-110)
Second comparator
Second grape variety to evaluate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycaemic response
Time Frame: 0 minutes
Assessment of serum glucose evolution after consuming 50 g of carbohydrates in grapes
0 minutes
Glycaemic response
Time Frame: 15 minutes
Assessment of serum glucose evolution after consuming 50 g of carbohydrates in grapes
15 minutes
Glycaemic response
Time Frame: 30 minutes
Assessment of serum glucose evolution after consuming 50 g of carbohydrates in grapes
30 minutes
Glycaemic response
Time Frame: 60 minutes
Assessment of serum glucose evolution after consuming 50 g of carbohydrates in grapes
60 minutes
Glycaemic response
Time Frame: 90 minutes
Assessment of serum glucose evolution after consuming 50 g of carbohydrates in grapes
90 minutes
Glycaemic response
Time Frame: 120 minutes
Assessment of serum glucose evolution after consuming 50 g of carbohydrates in grapes
120 minutes
Insulinemic response
Time Frame: 0 minutes
Assessment of serum insulin evolution after consuming 50 g of carbohydrates in grapes
0 minutes
Insulinemic response
Time Frame: 15 minutes
Assessment of serum insulin evolution after consuming 50 g of carbohydrates in grapes
15 minutes
Insulinemic response
Time Frame: 30 minutes
Assessment of serum insulin evolution after consuming 50 g of carbohydrates in grapes
30 minutes
Insulinemic response
Time Frame: 60 minutes
Assessment of serum insulin evolution after consuming 50 g of carbohydrates in grapes
60 minutes
Insulinemic response
Time Frame: 90 minutes
Assessment of serum insulin evolution after consuming 50 g of carbohydrates in grapes
90 minutes
Insulinemic response
Time Frame: 120 minutes
Assessment of serum insulin evolution after consuming 50 g of carbohydrates in grapes
120 minutes
Insulin Resistance Index (HOMA-IR) response
Time Frame: 0 minutes
Assessment of insulin resistance evolution after consuming 50 g of carbohydrates in grapes
0 minutes
Insulin Resistance Index (HOMA-IR) response
Time Frame: 15 minutes
Assessment of insulin resistance evolution after consuming 50 g of carbohydrates in grapes
15 minutes
Insulin Resistance Index (HOMA-IR) response
Time Frame: 30 minutes
Assessment of insulin resistance evolution after consuming 50 g of carbohydrates in grapes
30 minutes
Insulin Resistance Index (HOMA-IR) response
Time Frame: 60 minutes
Assessment of insulin resistance evolution after consuming 50 g of carbohydrates in grapes
60 minutes
Insulin Resistance Index (HOMA-IR) response
Time Frame: 90 minutes
Assessment of insulin resistance evolution after consuming 50 g of carbohydrates in grapes
90 minutes
Insulin Resistance Index (HOMA-IR) response
Time Frame: 120 minutes
Assessment of insulin resistance evolution after consuming 50 g of carbohydrates in grapes
120 minutes
Metabolome composition
Time Frame: 120 minutes
Metabolomic analysis after grapes consumption
120 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total cholesterol
Time Frame: 0 minutes
Serum total cholesterol in fasting state
0 minutes
LDL - cholesterol
Time Frame: 0 minutes
Serum LDL-cholesterol in fasting state
0 minutes
HDL-cholesterol
Time Frame: 0 minutes
Serum HDL-cholesterol in fasting state
0 minutes
Triglycerides
Time Frame: 0 minutes
Serum triglycerides in the fasting state
0 minutes
ALT
Time Frame: 0 minutes
Serum ALT levels in fasting state
0 minutes
AST
Time Frame: 0 minutes
Serum AST levels in fasting state
0 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Santiago Navas-Carretero, PhD, University of Navarra

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 25, 2024

Primary Completion (Actual)

November 29, 2024

Study Completion (Actual)

November 29, 2024

Study Registration Dates

First Submitted

December 19, 2024

First Submitted That Met QC Criteria

December 19, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 19, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SUGARGAP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe